National and Kapodistrian University of Athens
Mελέτη της αλληλεπίδρασης των ιών Flaviviridae και άλλων RNA ιών, όπως ο SARS-CoV-2, με σηματοδοτικά μονοπάτια του κυττάρου και εφαρμογή σε θεραπευτικές προσεγγίσεις
Abstract
dc:descriptionObjective: The overarching aim of the present doctoral thesis is to investigate the interaction of the RNA viruses HCV, DENV, and SARS-CoV-2 with the key cellular signaling pathways of hypoxia and catecholamine biosynthesis and metabolism, with the goal of identifying novel molecular mechanisms of viral pathogenesis. Introduction: Hepatitis C virus (HCV) and dengue virus (DENV) belong to the Flaviviridae family and constitute major causative agents of severe diseases with high mortality rates worldwide. Both pathogens possess a single-stranded positive-sense RNA genome, and their life cycle takes place exclusively in the cytoplasm of the host cell. Despite significant advances in the development of antiviral therapies against HCV in recent years, major challenges remain, including the high cost of treatment, the emergence of resistant strains, and the persistent risk of hepatocellular carcinoma development. Furthermore, the lack of approved specific therapies for DENV, combined with the frequent occurrence of co-infections, particularly in geographical regions with high prevalence of both viruses, highlights the urgent need for the identification of novel effective therapeutic targets. The recent COVID-19 pandemic underscored the importance of an in-depth understanding of the molecular nodes governing the interaction between the RNA virus SARS-CoV-2 and the host, given the functional and structural similarities of its life cycle to those of HCV and DENV. Within the framework of a long-standing collaboration between the Laboratory of Molecular Virology of the Hellenic Pasteur Institute and the Section of Biochemistry and Molecular Biology of the National and Kapodistrian University of Athens, experimental data suggested a potential association between infection by the aforementioned viruses and the function of the catecholamine biosynthetic and metabolic pathway. Specifically, a regulatory association was identified between HCV and DENV infection and the expression of L-Dopa decarboxylase (DDC), an enzyme responsible for dopamine biosynthesis. This finding was attributed, at least in part, to the physical interaction of DDC with the p55 regulatory subunit of phosphoinositide 3-kinase (PI3K), a central component of the PI3K/AKT signaling pathway. In parallel, published studies from the same research group demonstrated that replication of HCV and DENV is enhanced under hypoxic conditions, while reduced oxygen tension exerts a suppressive effect on DDC expression levels.Specific Objectives: Taking these findings into account, the present doctoral thesis investigated: (a) the involvement of hypoxia-inducible factors (HIFs) in the suppression of L-Dopa decarboxylase (DDC) expression observed during viral infection, (b) the functional significance of DDC biosynthetic activity in viral replication, and (c) based on the statistically significant co-expression of DDC with the ACE2 locus, which encodes the receptor protein mediating SARS-CoV-2 entry into host cells, as well as data indicating interactions of viral proteins with monoamine oxidase A (MAO-A) and the involvement of catechol-O-methyltransferase (COMT) in infection, the association of DDC with SARS-CoV-2 infection was examined for the first time, both in cultured epithelial cells and in clinical patient samples. Summary of Results and Conclusions: The experimental findings of this doctoral thesis attributed the negative impact of HCV and DENV infection on L-Dopa decarboxylase (DDC) expression levels to the activity of hypoxia-inducible factors (HIFs). This conclusion was supported by the observation that the presence of an HIF inhibitor attenuated the infection-induced reduction in DDC protein levels. Furthermore, the critical role of DDC biosynthetic function in suppressing the replication of these viruses was demonstrated. Specifically, enhanced viral proliferation was observed in cellular systems where DDC gene expression was silenced, accompanied by a reduction in the inhibitory effect of the enzyme substrates L-Dopa and 5-hydroxytryptophan (5-HTP) on viral replication in the same cells. In addition, exogenous administration of dopamine resulted in a significant suppression of viral replication, an effect shown to be independent of dopamine D2 receptor signaling. Notably, chemical inhibition of dopamine transporters led to increased replication of both viruses, a finding attributed to reduced uptake of the molecule from the extracellular environment. Moreover, in the case of HCV, dopamine exerted its antiviral effect through modulation of intracellular reactive oxygen species (ROS) levels. Specifically, co-administration of dopamine and reduced glutathione, a widely used antioxidant, abolished the effect of dopamine on viral propagation. In contrast, during DENV infection, although the importance of intracellular dopamine accumulation was confirmed, its antiviral effect was found to be independent of ROS regulation. The association between SARS-CoV-2 infection and L-Dopa decarboxylase (DDC) expression, as well as the broader catecholamine biosynthetic and metabolic pathway, was investigated in both clinical patient samples and cultured cell models. In patients with mild or asymptomatic COVID-19, increased DDC expression was observed compared to the negative control group, alongside a statistically significant inverse correlation between DDC levels and viral RNA. Additionally, strong correlations were detected between DDC expression and the dACE2 gene, an interferon-inducible isoform of ACE2, suggesting a potential role of DDC in a coordinated antiviral immune response of the host cell. In contrast, patients with severe COVID-19 exhibited marked suppression of DDC expression, with levels even lower than those of the control group. These findings identify DDC, for the first time, as a reliable molecular prognostic biomarker of COVID-19 disease severity. Furthermore, patient samples from severe cases revealed extensive alterations in dopamine biosynthesis and metabolism, including decreased DDC expression and increased mRNA levels of monoamine oxidases A and B (MAO-A and MAO-B), enzymes involved in dopamine catabolism. These data underscore the importance of dopamine as a potential regulatory factor in viral infection. These findings were further validated in infected VeroE6 epithelial cells derived from the kidney of the African green monkey (Chlorocebus sabaeus). Moreover, consistent with observations in HCV and DENV, exogenous administration of non-cytotoxic concentrations of dopamine or L-Dopa in infected cells led to a significant reduction in SARS-CoV-2 spread, as evidenced by decreased virus-induced cytopathic effects. Administration of L-Dopa or dopamine may therefore represent a potential antiviral strategy, particularly in immunocompromised patients, a condition associated with increased SARS-CoV-2 viral loads. In conclusion, the collective findings of this doctoral thesis demonstrate a direct link between neuromolecules and viral infections.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Bekoulis, Georgios
- Μπεκούλης, Γεώργιος
Subjects
dc:subject × 19- SARS-CoV-2
- Δάγκειος πυρετός
- Ιός της ηπατίτιδας C
- L-DOPA αποκαρβοξυλάση (DDC)
- Κατεχολαμίνες
- Φλεγμονώδης απόκριση
- Υποξική σηματοδότηση
- Dengue virus (DENV)
- HCV infection
- L-dopa decarboxylase
- Inflammatory response
- Antivirals
- Hypoxia signaling
- Επιστήμες Υγείας
- Ιατρική και Επιστήμες Υγείας
- Λοιμώδη νοσήματα
- Health Sciences
- Medical and Health Sciences
- Infectious Diseases
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/61420